Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sphingosine-1-phosphate receptor 5 (S1P5) is a G protein-coupled receptor that binds the lipid signaling molecule sphingosine-1-phosphate (S1P). It plays a crucial role in immune cell trafficking, central nervous system function, and lymphocyte regulation. S1P5 primarily signals through Gαi and G12/13 subunits, leading to downstream effects on cell migration, cytoskeleton organization, and immune cell trafficking. It is expressed in tissues such as the spleen, natural killer cells, patrolling monocytes, certain T cell subsets and oligodendrocytes within the CNS, where it is involved in remyelination processes relevant for diseases like multiple sclerosis. S1P5 influences differentiation of effector/memory T cells, regulating tissue residency during immune responses.
Modulation of S1P receptor signaling, including Gαi and G12/13 pathways, affecting immune cell trafficking, cytoskeleton organization, and remyelination.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sphingosine-1-phosphate receptor 5 (S1P5).